No Need for Urgent Revisiting of Kalaemia Levels in Guidelines Despite Use of Mineralocorticoid Receptor Antagonists: Bring in More Evidence

European Journal of Heart Failure - United States
doi 10.1002/ejhf.1230
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

No Urgent Need for Revisiting Kalaemia Guidelines: Rebuttal

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2018English

Mineralocorticoid Receptor Antagonists (MRAs): More Attention Required (To Prescription)!

Kardiologia Polska
Cardiovascular MedicineCardiology
2018English

Mineralocorticoid Receptor Antagonists for Heart Failure

Expert Opinion on Pharmacotherapy
MedicinePharmacology
2011English

The Use of Mineralocorticoid Receptor Antagonists in the Pre Vention of Atrial Fibrillation

The Russian Archives of Internal Medicine
2019English

Third-Generation Mineralocorticoid Receptor Antagonists

Journal of Cardiovascular Pharmacology
Cardiovascular MedicinePharmacologyCardiology
2016English

Mineralocorticoid Receptor Antagonists: New Extended Roles in Cardio- And Nephroprotection

Medical Council
2018English

New Evidence Supporting the Use of Mineralocorticoid Receptor Blockers in Drug-Resistant Hypertension

Current Hypertension Reports
Internal Medicine
2016English

Managing Resistant Hypertension: Focus on Mineralocorticoid-Receptor Antagonists

Vascular Health and Risk Management
2017English

Mineralocorticoid Receptor Antagonists for Heart Failure: Systematic Review and Meta-Analysis

BMC Cardiovascular Disorders
Cardiovascular MedicineCardiology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy